Kathryn Edenborough

565 total citations
18 papers, 395 citations indexed

About

Kathryn Edenborough is a scholar working on Epidemiology, Infectious Diseases and Immunology. According to data from OpenAlex, Kathryn Edenborough has authored 18 papers receiving a total of 395 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 5 papers in Infectious Diseases and 5 papers in Immunology. Recurrent topics in Kathryn Edenborough's work include Influenza Virus Research Studies (6 papers), Respiratory viral infections research (5 papers) and Viral Infections and Vectors (4 papers). Kathryn Edenborough is often cited by papers focused on Influenza Virus Research Studies (6 papers), Respiratory viral infections research (5 papers) and Viral Infections and Vectors (4 papers). Kathryn Edenborough collaborates with scholars based in Australia, United States and Germany. Kathryn Edenborough's co-authors include Lorena E. Brown, Brad Gilbertson, Edin Mifsud, Jodie McVernon, Amabel C. L. Tan, David C. Jackson, Weiguang Zeng, Emma R. Job, Patrick C. Reading and Johanna E. Fraser and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Journal of Virology.

In The Last Decade

Kathryn Edenborough

17 papers receiving 388 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kathryn Edenborough Australia 10 209 159 111 51 46 18 395
Jianhua Le United States 9 389 1.9× 269 1.7× 183 1.6× 95 1.9× 28 0.6× 11 623
Ivonne Rubio Uruguay 12 312 1.5× 179 1.1× 59 0.5× 80 1.6× 33 0.7× 30 481
Regina K. Rowe United States 8 103 0.5× 77 0.5× 87 0.8× 58 1.1× 22 0.5× 11 298
Filippo Turrini Italy 15 232 1.1× 248 1.6× 171 1.5× 127 2.5× 68 1.5× 24 640
Daniel Portsmouth Austria 13 246 1.2× 85 0.5× 170 1.5× 52 1.0× 59 1.3× 20 364
Kimberly A. Kegerreis United States 9 93 0.4× 226 1.4× 99 0.9× 64 1.3× 82 1.8× 9 408
Lindy Liu United States 10 343 1.6× 98 0.6× 151 1.4× 134 2.6× 62 1.3× 19 532
Seleeke Flingai United States 9 78 0.4× 146 0.9× 142 1.3× 134 2.6× 67 1.5× 13 385
Michael Parker United Kingdom 4 201 1.0× 103 0.6× 205 1.8× 87 1.7× 131 2.8× 8 465
Elizabeth A. Dietrich United States 13 72 0.3× 71 0.4× 253 2.3× 82 1.6× 146 3.2× 27 466

Countries citing papers authored by Kathryn Edenborough

Since Specialization
Citations

This map shows the geographic impact of Kathryn Edenborough's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathryn Edenborough with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathryn Edenborough more than expected).

Fields of papers citing papers by Kathryn Edenborough

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathryn Edenborough. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathryn Edenborough. The network helps show where Kathryn Edenborough may publish in the future.

Co-authorship network of co-authors of Kathryn Edenborough

This figure shows the co-authorship network connecting the top 25 collaborators of Kathryn Edenborough. A scholar is included among the top collaborators of Kathryn Edenborough based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathryn Edenborough. Kathryn Edenborough is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Edenborough, Kathryn, et al.. (2025). Complete inactivation of orthoflavi- and alphaviruses by acetone for safe titering by ELISA. Journal of Virological Methods. 335. 115146–115146. 1 indexed citations
2.
Edenborough, Kathryn, Endah Supriyati, Suzanne M. Dufault, et al.. (2024). Dengue virus genomic surveillance in the applying Wolbachia to eliminate dengue trial reveals genotypic efficacy and disruption of focal transmission. Scientific Reports. 14(1). 28004–28004.
3.
Edenborough, Kathryn, Eike Steinig, Brendan Quinn, et al.. (2024). Mpox genomics in outbreak control: challenges and limitations. The Lancet Microbe. 6(3). 100999–100999. 1 indexed citations
4.
Edenborough, Kathryn, Heather A. Flores, Cameron P. Simmons, & Johanna E. Fraser. (2021). Using Wolbachia to Eliminate Dengue: Will the Virus Fight Back?. Journal of Virology. 95(13). e0220320–e0220320. 29 indexed citations
5.
Edenborough, Kathryn, Andre Mu, Kristin Mühldorfer, et al.. (2020). Microbiomes in the insectivorous bat species Mops condylurus rapidly converge in captivity. PLoS ONE. 15(3). e0223629–e0223629. 18 indexed citations
6.
Edenborough, Kathryn, Angelika Lander, Andreas Nitsche, et al.. (2020). Utility of primary cells to examine NPC1 receptor expression in Mops condylurus, a potential Ebola virus reservoir. PLoS neglected tropical diseases. 14(1). e0007952–e0007952. 9 indexed citations
7.
Edenborough, Kathryn, Angelika Lander, Emmanuel Couacy‐Hymann, et al.. (2019). Dendritic Cells Generated From Mops condylurus, a Likely Filovirus Reservoir Host, Are Susceptible to and Activated by Zaire Ebolavirus Infection. Frontiers in Immunology. 10. 2414–2414. 3 indexed citations
8.
Gilbertson, Brad, Kathryn Edenborough, Jodie McVernon, & Lorena E. Brown. (2019). Inhibition of Influenza A Virus by Human Infant Saliva. Viruses. 11(8). 766–766. 7 indexed citations
9.
Edenborough, Kathryn, Simona Zoppi, Alessandro Dondo, et al.. (2017). Coronavirus and paramyxovirus in bats from Northwest Italy. BMC Veterinary Research. 13(1). 396–396. 47 indexed citations
10.
Edenborough, Kathryn, Karen Laurie, Manabu Yamada, et al.. (2015). Predicting Disease Severity and Viral Spread of H5N1 Influenza Virus in Ferrets in the Context of Natural Exposure Routes. Journal of Virology. 90(4). 1888–1897. 13 indexed citations
11.
Chua, Brendon Y., Chinn Yi Wong, Edin Mifsud, et al.. (2015). Inactivated Influenza Vaccine That Provides Rapid, Innate-Immune-System-Mediated Protection and Subsequent Long-Term Adaptive Immunity. mBio. 6(6). e01024–15. 32 indexed citations
12.
Edenborough, Kathryn & Glenn A. Marsh. (2014). Reverse genetics: Unlocking the secrets of negative sense RNA viral pathogens. 4(4). 16–16. 3 indexed citations
13.
Olson, Matthew R., et al.. (2014). CD154+ CD4+ T‐cell dependence for effective memory influenza virus‐specific CD8+ T‐cell responses. Immunology and Cell Biology. 92(7). 605–611. 6 indexed citations
14.
Olson, Matthew R., Shirley G. K. Seah, Jolie G. Cullen, et al.. (2014). Helping Themselves: Optimal Virus-Specific CD4 T Cell Responses Require Help via CD4 T Cell Licensing of Dendritic Cells. The Journal of Immunology. 193(11). 5420–5433. 9 indexed citations
15.
Short, Kirsty R., Patrick C. Reading, Lorena E. Brown, et al.. (2013). Influenza-Induced Inflammation Drives Pneumococcal Otitis Media. Infection and Immunity. 81(3). 645–652. 50 indexed citations
16.
Job, Emma R., Barbara Bottazzi, Brad Gilbertson, et al.. (2013). Serum Amyloid P Is a Sialylated Glycoprotein Inhibitor of Influenza A Viruses. PLoS ONE. 8(3). e59623–e59623. 39 indexed citations
17.
Edenborough, Kathryn, Brad Gilbertson, & Lorena E. Brown. (2012). A Mouse Model for the Study of Contact-Dependent Transmission of Influenza A Virus and the Factors That Govern Transmissibility. Journal of Virology. 86(23). 12544–12551. 38 indexed citations
18.
Tan, Amabel C. L., Edin Mifsud, Weiguang Zeng, et al.. (2012). Intranasal Administration of the TLR2 Agonist Pam2Cys Provides Rapid Protection against Influenza in Mice. Molecular Pharmaceutics. 9(9). 2710–2718. 90 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026